Closed

Intent to Sole Source - X10 VIALS of Floxuridine 500MG vials

Deadline:03 Jun 2026, 12:00 GMT-4

Tender information

SAM.gov

Bethesda, United States

Type: Special Notice
Procedure: Special Notice
Ref. number: 202ca27302b44995b410f04983aa081b
NAICS: 325412

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Cardinal…

Health dba Specialty Pharmaceutical Services (JND Therapeutics). Acquisition Description: The purpose of this acquisition is to purchase X10 VIALS of Floxuridine 500MG vials for injections for patient care. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemen

ted by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement th

Show all tender information

Documents

Show all important dates